arXiv · 2610.20833
Challenges and Opportunities in Statistical Analyses and Designs for Neuroscience Clinical Trials
Abstract
Drug development is a complex, costly, and high-risk process, with neuroscience representing one of the most challenging therapeutic areas due to the complexity of neurodegenerative and neuropsychiatric disorders. Neuroscience clinical trials face unique barriers, making the adoption of innovative statistical methods in study design, execution, and analysis especially critical for improving clarity, feasibility, efficiency, and validity in the drug development process. The ASA Biopharmaceutical Section Neuroscience Scientific Working Group (SWG) was formed to advance statistical research and address these distinct challenges. This landscape paper provides an overview of key challenges and opportunities in statistical methods and trial designs for neuroscience, offering insights to guide future research and practice in this evolving field.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Jia Jia, Man Jin, Bo Lu, Jianchang Lin, Inna Perevozskaya, Hui Yang, Nan Hu, Yi Lu, Qi Q, Jonathan Hartzel, Shouhao Zhou, Shyla Jagannatha, Wei Michelle Zhang. 2026-10-14. Challenges and Opportunities in Statistical Analyses and Designs for Neuroscience Clinical Trials. https://arxiv.org/abs/2610.20833
Cite the original work for its findings. Save a collection to share your selection of sources.